RxDoctor Payments Data

Farrah Gardner, NP

Family · Centre, ALNPI 1477915569

Payments from drug & device makers

$3,076in general payments, 2019–2025

Across 194 payments — averaging $15.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$653
  • AbbVie$407
  • Lilly USA, LLC$357
  • AstraZeneca$242
  • Pfizer$239
  • Merck$158
  • plus $1K from 28 others

What the payments were for

  • Food & beverage$3,076100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,076 in reported general payments places this provider in the 80th percentile of 3,415 family providers in Alabama.

See all family providers in Alabama

Medicare billing

Part B allowed, 2024
$6,789
Medicare patients
58
Services billed
296

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide102$145,663
JardianceEmpagliflozin16$28,164
Trelegy ElliptaFluticasone/Umeclidin/Vilanter30$27,473
TrulicityDulaglutide20$24,821
OzempicSemaglutide23$24,170
XareltoRivaroxaban11$6,956
Albuterol Sulfate HfaAlbuterol Sulfate136$4,081
Rosuvastatin Calcium118$1,733
Omeprazole116$1,712
Atorvastatin Calcium142$1,338
Levothyroxine Sodium93$1,334
Buspirone Hcl73$1,083
Duloxetine Hcl59$1,031
Amlodipine Besylate130$955
Hydroxyzine Pamoate37$946

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$357$170,484122 claims
Boehringer IngelheimJardiance$27$28,16416 claims
GSKTrelegy Ellipta$653$27,47330 claims
Novo NordiskOzempic$99$24,17023 claims
Johnson & JohnsonXarelto$16$6,95611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,415 family providers in Alabama.

Other family in Centre

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →